Medicaid and GLP-1 Coverage: A Complicated Patchwork
Medicaid is the health insurance safety net for over 90 million Americans, but when it comes to GLP-1 weight loss medications, coverage is a patchwork that varies enormously by state. Some states have embraced these medications and cover them with relatively straightforward prior authorization. Others exclude anti-obesity drugs entirely from their formularies.
If you are on Medicaid and considering a GLP-1 medication like Wegovy or Zepbound, the first thing you need to do is figure out what your specific state covers.
Why Medicaid Coverage Varies So Much
Unlike Medicare (which is a federal program) or commercial insurance (which follows market dynamics), Medicaid is jointly funded by the federal government and individual states. Each state operates its own Medicaid program with its own rules, formulary, and coverage decisions. States can choose to:
- Cover all FDA-approved anti-obesity medications
- Cover some but not others (for example, covering Saxenda but not Wegovy)
- Cover GLP-1s only for the diabetes indication
- Exclude weight loss drugs entirely
- Use Medicaid managed care organizations (MCOs) that each set their own formularies
This means a Medicaid beneficiary in New York may have full access to Wegovy, while a beneficiary in Texas with similar health needs may have no coverage at all.
State-by-State Medicaid GLP-1 Coverage
The following table reflects our research as of early 2026. Coverage can change as states update their preferred drug lists. Always confirm with your state Medicaid program or MCO.
| State | GLP-1 for Weight Loss | Notes |
|---|---|---|
| Alabama | Limited | Diabetes indication primarily |
| Alaska | Limited | Small Medicaid population, limited formulary |
| Arizona | Some coverage | Through AHCCCS managed care plans |
| Arkansas | Limited | Diabetes indication primarily |
| California | Covered with PA | Medi-Cal covers Wegovy and Saxenda with prior auth |
| Colorado | Covered with PA | Progressive coverage policies |
| Connecticut | Covered with PA | Requires specialist referral in some plans |
| Delaware | Limited | Varies by MCO |
| Florida | Limited | Most MCOs exclude weight loss drugs |
| Georgia | Limited | Diabetes indication primarily |
| Hawaii | Some coverage | Varies by managed care plan |
| Idaho | Limited | Diabetes indication primarily |
| Illinois | Covered with PA | Covers Wegovy through MCOs |
| Indiana | Some coverage | Varies by managed care plan |
| Iowa | Limited | Strict criteria |
| Kansas | Limited | Diabetes indication primarily |
| Kentucky | Some coverage | Varies by MCO |
| Louisiana | Limited | Diabetes indication primarily |
| Maine | Covered with PA | MaineCare covers with documentation |
| Maryland | Some coverage | Varies by MCO |
| Massachusetts | Covered with PA | MassHealth covers with prior auth |
| Michigan | Some coverage | Varies by Medicaid Health Plan |
| Minnesota | Covered with PA | MinnesotaCare and MA cover with PA |
| Mississippi | Limited | Diabetes indication primarily |
| Missouri | Limited | Varies by managed care plan |
| Montana | Limited | Small Medicaid program |
| Nebraska | Limited | Diabetes indication primarily |
| Nevada | Some coverage | Varies by MCO |
| New Hampshire | Some coverage | Managed care dependent |
| New Jersey | Some coverage | Varies by MCO |
| New Mexico | Some coverage | Centennial Care plans vary |
| New York | Covered with PA | Medicaid covers Wegovy and Zepbound with PA |
| North Carolina | Some coverage | Through Medicaid managed care (launched 2024) |
| North Dakota | Limited | Small program, strict criteria |
| Ohio | Some coverage | Varies by managed care plan |
| Oklahoma | Limited | Diabetes indication primarily |
| Oregon | Covered with PA | Oregon Health Plan covers with PA |
| Pennsylvania | Some coverage | Varies by MCO |
| Rhode Island | Some coverage | Small program, varies by plan |
| South Carolina | Limited | Primarily diabetes indication |
| South Dakota | Limited | Strict formulary |
| Tennessee | Limited | TennCare varies by MCO |
| Texas | Limited | Most STAR plans exclude weight loss drugs |
| Utah | Limited | Diabetes indication primarily |
| Vermont | Covered with PA | Green Mountain Care covers with PA |
| Virginia | Some coverage | Varies by managed care plan |
| Washington | Covered with PA | Apple Health covers with prior auth |
| West Virginia | Limited | Diabetes indication primarily |
| Wisconsin | Some coverage | Varies by managed care plan |
| Wyoming | Limited | Fee-for-service, strict formulary |
| Washington D.C. | Covered with PA | Covers through managed care plans |
Key: "Covered with PA" means the state Medicaid program generally covers GLP-1s for weight loss with prior authorization. "Some coverage" means it depends on your specific managed care plan. "Limited" means coverage is primarily available for the diabetes indication only.
How to Check Your Specific Medicaid Coverage
- Identify your Medicaid managed care organization (MCO). Most Medicaid beneficiaries are enrolled in an MCO, not fee-for-service Medicaid. Your MCO card will show the plan name.
- Call your MCO's member services line. Ask specifically: "Does my plan cover Wegovy [or Zepbound] for weight management? What are the prior authorization requirements?"
- Check the preferred drug list (PDL). Your state Medicaid website or MCO website should publish a preferred drug list that shows covered medications.
- Ask your provider. Many GLP-1 clinics and primary care providers have experience navigating Medicaid prior authorizations and know your state's specific requirements.
Common Medicaid Prior Authorization Requirements
For states that do cover GLP-1 weight loss medications, prior authorization criteria typically include:
- BMI of 30 or higher, or 27+ with a comorbidity
- Documentation of prior weight management attempts (usually 3 to 6 months)
- Prescriber must be a physician, NP, or PA
- Some states require ongoing documentation of weight loss progress at 3 to 6 month intervals
- Continuation criteria may require a minimum of 5% body weight loss within the first 3 to 6 months
What If Your State Does Not Cover GLP-1s?
If your state Medicaid program excludes anti-obesity medications, you still have options:
Manufacturer Patient Assistance Programs
- Novo Nordisk PAP: Provides Wegovy at no cost to eligible patients who are uninsured or underinsured and meet income criteria
- Eli Lilly Solutions Center: Offers Zepbound assistance for eligible low-income patients
- These programs typically require proof of income below 400% of the federal poverty level
340B Drug [Pricing](/cost-guide)
If you receive care at a Federally Qualified Health Center (FQHC) or other 340B-eligible facility, the facility may be able to obtain GLP-1 medications at deeply discounted prices and pass those savings along to patients. Ask your community health center about 340B pricing.
Advocacy for Coverage Changes
Contact your state legislators and Medicaid agency to advocate for GLP-1 coverage. Many states are actively reconsidering their exclusions as evidence mounts that treating obesity reduces long-term Medicaid costs for diabetes, cardiovascular disease, and other complications.
Diabetes Pathway
If you have both obesity and type 2 diabetes, GLP-1 medications are much more likely to be covered for the diabetes indication. Talk to your doctor about whether Ozempic or Mounjaro would be appropriate for your situation.
Find Medicaid-Friendly GLP-1 Providers
Search our clinic directory to find GLP-1 providers in your area. Many clinics in our network accept Medicaid and can help navigate your state's coverage process.